For the first time in its history, Maryland has chosen to author its own vaccine guidance rather than defer to federal protocols, issuing state-specific recommendations for the 2026-2027 respiratory virus season. The decision emerges from a period of federal uncertainty around respiratory illness prevention, prompting state officials to trust their own epidemiological data over a shifting national consensus. It is a quiet but consequential act — one that raises enduring questions about whether a single national voice can truly serve the full diversity of American public health.